5:41 03/05/2016 What's AEterna Zentaris Inc. (USA) Downside After Today's Huge Decline?
What's AEterna Zentaris Inc. (USA) Downside After Today's Huge Decline?
Franklin Independent - May 3, 2016
The stock decreased 3.21% or $0.13 during the last trading session, hitting $3.92. About 214,998 shares traded hands. AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) has declined 56.44% since September 25, 2015 and is downtrending. It has underperformed ...
AEterna Zentaris Inc. (NASDAQ:AEZS) Comprehensive Income At $1.132 Millions ... - Stocks Daily
Maxim Group Reaffirms Buy Rating for AEterna Zentaris Inc. (AEZS) - Web Breaking News

13:45 29/04/2016 Biotech Updates: Analysts Comment on AEterna Zentaris Inc. (USA) (AEZS), Keryx ...
Biotech Updates: Analysts Comment on AEterna Zentaris Inc. (USA) (AEZS), Keryx ...
Smarter Analyst - Apr 29, 2016
In a research issued yesterday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), with a price target of $11, after the biotech company announced the acquisition of “exclusive promotional ...

15:26 31/03/2016 Canaccord Slashes Price Target for AEterna Zentaris Inc. (USA) (AEZS ...
Canaccord Slashes Price Target for AEterna Zentaris Inc. (USA) (AEZS ...
Smarter Analyst - Mar 31, 2016
Canaccord analyst Neil Maruoka expressed a cautious stance today on drug maker AEterna Zentaris Inc. (USA)(NASDAQ:AEZS), after the company reported fourth-quarter financial results that were below his expectations on a lighter top line and higher ...
Tenor Capital Management Exits Position in AEterna Zentaris (USA) (AEZS) - Street Edition

16:21 02/12/2015 Canaccord Weighs In On AEterna Zentaris Inc. (USA) (AEZS) Following Co ...
Canaccord Weighs In On AEterna Zentaris Inc. (USA) (AEZS) Following Co ...
Smarter Analyst - Dec 2, 2015
Canaccord's healthcare analyst Neil Maruoka weighed in on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the company announced the finalization of a co-promotion agreement with Armune BioScience for APIFINY, a test for prostate cancer.
Aeterna Zentaris Rises on Finalized Marketing Agreement - 24/7 Wall St.
Aeterna Zentaris and Armune BioScience Finalize Co-Marketing Agreement for ... - Business Wire (press release)

16:45 23/11/2015 Maxim Introduces New Price Target For AEterna Zentaris Inc. (USA) (AEZS) On ...
Maxim Introduces New Price Target For AEterna Zentaris Inc. (USA) (AEZS) On ...
Smarter Analyst - Nov 23, 2015
In a research report released today, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc.

20:17 10/11/2015 Here's Why Canaccord Upgraded AEterna Zentaris Inc. (USA) (AEZS) to ...
Here's Why Canaccord Upgraded AEterna Zentaris Inc. (USA) (AEZS) to ...
Smarter Analyst - Nov 10, 2015
In a research report published yesterday, Canaccord analyst Neil Maruoka upgraded shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) from a Hold to a Speculative Buy rating, while reducing the price target to $0.10 (from $0.15), which represents a ...

21:22 06/11/2015 Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 3Q Update
Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 3Q Update
Smarter Analyst - Nov 6, 2015
In a research report published Friday, Maxim Group analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a $2.00 price target, following the company's third-quarter financial results and update on its ...

16:57 13/10/2015 Maxim Weighs In On AEterna Zentaris Inc. (USA) (AEZS) As The DSMB Recommends ...
Maxim Weighs In On AEterna Zentaris Inc. (USA) (AEZS) As The DSMB Recommends ...
Smarter Analyst - Oct 13, 2015
Maxim Group analyst Jason Kolbert came out today with a few insights on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS), after the company announced that the independent Data and Safety Monitoring Board (DSMB) gave the approval to continue the pivotal ...
Aeterna Zentaris: Data and Safety Monitoring Board Recommends Continuation of ... - PR Newswire (press release)
Aeterna Zentaris (AEZS) Announces DSMB Recommendation to Continue Phase 3 ... - StreetInsider.com

20:47 28/09/2015 Maxim Weighs In On AEterna Zentaris Inc. (USA) Following Positive Clinical ...
Maxim Weighs In On AEterna Zentaris Inc. (USA) Following Positive Clinical ...
Smarter Analyst - Sep 28, 2015
In a research report issued today, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a $2 price target, after the company announced that its lead oncology compound, zoptarelin doxorubicin ...
AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) Gets TSX Approval of Series 'B ... - Journal Transcript
Biotech Stocks With Optimistic Trend - AEterna Zentaris Inc. (USA) (NASDAQ ... - Wall Street Observer

15:57 17/08/2015 Canaccord Slashes Price Target for AEterna Zentaris Inc. (USA) on Back of ...
Canaccord Slashes Price Target for AEterna Zentaris Inc. (USA) on Back of ...
Smarter Analyst - Aug 17, 2015
In a research report released Monday, Canaccord analyst Neil Maruoka maintained a Hold rating on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) and reduced the price target to $0.15 (from $0.70), citing substantial dilution risk. Maruoka noted, “During the ...
Aeterna Zentaris Inc (NASDAQ:AEZS) Had Its Price Target Downgraded by 20.00 ... - OctaFinance.com